Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9783550
Highly potent inhibitors of porcupine
granted -
US 9775876
Compositions and methods for CaMKII inhibitors and uses thereof
granted -
US 9777024
Heteroaryl inhibitors of PDE4
granted -
US 9771366
Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors
granted -
US 9771585
miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
granted -
US 9771361
Inhibitors of influenza viruses replication
granted -
US 9771337
Neprilysin inhibitors
granted -
US 9765055
Intramolecular hydrogen-bonded nitric oxide synthase inhibitors
granted -
US 9765099
STAT6 inhibitors
granted -
US 9765066
Selective HDAC1 and HDAC2 inhibitors
granted -
US 9757382
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 9752144
Inhibitors of MYH7B and uses thereof
granted -
US 9750717
Inhibitors of CD40-TRAF6 interaction
granted -
US 9750748
Pyridazinones as DAAO enzyme inhibitors
granted -
US 9745314
MDM2 inhibitors and therapeutic methods using the same
granted -
US 9745255
Meta-substituted biphenyl peripherally restricted FAAH inhibitors
granted -
US 9738629
Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
granted -
US 9738641
Bicyclic inhibitors
granted -
US 9737598
CD200 inhibitors and methods of use thereof
granted -
US 9732095
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 9732070
Protein kinase C inhibitors and uses thereof
granted -
US 9725448
Neprilysin inhibitors
granted -
US 9725470
Substituted naphthyridines as JAK kinase inhibitors
granted -
US 9724350
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted